ArticleJournal of pharmacy & bioallied sciences2025
Study Protocol: Comparison of Clinical Pregnancy Outcomes of Intracytoplasmic Sperm Injection (ICSI) Using Testicular and Ejaculated Spermatozoa in Male Patients with High DNA Fragmentation.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to compare the clinical pregnancy outcome of intracytoplasmic sperm injection (ICSI) using testicular and ejaculated spermatozoa in male patients with high deoxyribonucleic acid (DNA) fragmentation. Patients diagnosed with high DNA fragmentation levels in sperm DNA fragmentation (SDF) tests using sperm chromatin dispersion (SCD) are categorized into two groups one including the male patient undergoing ICSI with ejaculated and another with testicular spermatozoa retrieved via testicular sperm aspiration (TESA). The study evaluates the clinical outcome including fertilization, implantation, and pregnancy rates, comparing the efficacy of testicular versus ejaculated sperm in overcoming the adverse effects of DNA fragmentation. By analyzing ICSI outcomes, the study seeks to establish standardized SDF testing protocols. Objective: The study aims to identify male partners with abnormal semen parameters and evaluate sperm DNA fragmentation (SDF) in both ejaculated and testicular sperm. Additionally, it seeks to assess the effectiveness of the SDF test in detecting DNA damage. Furthermore, the study compares the clinical pregnancy outcomes of ICSI using testicular and ejaculated spermatozoa in male patients with high DNA fragmentation. Methodology: The methodology involves patient consultation, consent, and screening for infections. Semen analysis and DNA fragmentation tests assess sperm quality. For azoospermic patients with high SDF, TESA retrieves sperm for ICSI and normal from ejaculate with high SDF. Outcomes are evaluated for treatment success and DNA integrity. Expected Results: Standardization of the SDF test, in which the best SDF test will be adopted, and a precise threshold will be used to determine the sperm DNA damage which may enhance the ICSI outcome, along with the difference between the ICSI outcome of both the testicular and ejaculated spermatozoa with high SDF. Study Implication: It helps in assessing the ICSI outcome in testicular and ejaculated spermatozoa in patients with high DNA fragmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.